EUVIMEDAtrasti EUVIMED
Leserbrief

Helicobacter pylori resistance in Australia: a call for active surveillance

Ravin Hettiarachchi iD, Raed Simhairi, Juliette Holland

Internal Medicine Journal · 2024

DOI: 10.1111/imj.16331 ↗

At a glance

Leserbrief in Internal Medicine Journal, 2024. Written by Ravin Hettiarachchi and 2 co-authors. Institution: Department of Microbiology, Laverty Pathology, Sydney, New South Wales, Australia. Major MEDLINE topics: Helicobacter pylori, Helicobacter Infections. Cited 1 times so far (Crossref); 3 references.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Santrauka nepasiekiama.

Subjects

MeSH terms (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsHumansWatchful WaitingAnti-Bacterial AgentsAustraliaClarithromycinDrug Resistance, BacterialMicrobial Sensitivity TestsMetronidazole

Substances

Anti-Bacterial AgentsClarithromycinMetronidazole

Authors and institutions

  • Department of Microbiology, Laverty Pathology, Sydney, New South Wales, Australia.
  • St George and Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

ORCID profiles: Ravin Hettiarachchi

Cite

APA

Hettiarachchi, R., Simhairi, R., & Holland, J. (2024). Helicobacter pylori resistance in Australia: a call for active surveillance. Internal Medicine Journal. https://doi.org/10.1111/imj.16331

Vancouver

Hettiarachchi R, Simhairi R, Holland J. Helicobacter pylori resistance in Australia: a call for active surveillance. Internal Medicine Journal. 2024. doi:10.1111/imj.16331

BibTeX
@article{Hettiarachchi2024,
  author = {Hettiarachchi, Ravin and Simhairi, Raed and Holland, Juliette},
  title = {Helicobacter pylori resistance in Australia: a call for active surveillance},
  journal = {Internal Medicine Journal},
  year = {2024},
  doi = {10.1111/imj.16331}
}
Start for free →